Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Short Communication
Authors: Norton, Joannaa; * | Gutierrez, Laure-Annea | Gourdeau, Christianb | Amieva, Hélènec | Bernier, Patrickd | Berr, Claudinea
Affiliations: [a] Institute for Neurosciences of Montpellier (INM), Inserm, University of Montpellier, Montpellier, France | [b] Department of Physics, Cégep Limoilou, Québec City, Canada | [c] INSERM, Bordeaux Population Health Research Center, UMR U1219, University of Bordeaux, Bordeaux, France | [d] Specialised Geriatric Services, CIUSSS Capitale-Nationale, Québec City, Canada
Correspondence: [*] Correspondence to: Joanna Norton, PhD, Inserm U1298, Institute for Neurosciences of Montpellier, 80 Avenue Augustin Fliche, 34295 Montpellier Cedex 5, France. E-mail: joanna.norton@inserm.fr.
Abstract: The Cognitive Quotient (QuoCo) classification algorithm monitoring decline on age- and education-adjusted Mini-Mental State Examination (MMSE)-derived cognitive charts has proved superior to the conventionally-used cut-off for identifying incident dementia; however, it remains to be tested in different settings. Data were drawn from the Three-City Cohort to 1) assess the screening accuracy of the QuoCo, and 2) compare its performance to that of serial MMSE tests applying different cut-offs. For the QuoCo, sensitivity was 74.2 (95% CI: 71.4–76.8) and specificity 84.1 (83.6–84.7) and for the MMSE < 24, 64.1 (61.1–67.0) and 94.8 (94.4–95.1), respectively; whereas overall accuracy and sensitivity was highest for MMSE cut-offs <25 and <26. User-friendly charts for mapping cognitive trajectories over visits with an alert for potentially ‘abnormal’ decline can be of practical use and encourage regular monitoring in primary care where the <24 cut-off is still widely used despite its poor sensitivity.
Keywords: Age, Alzheimer’s disease, cognitive decline, dementia, early detection, education
DOI: 10.3233/JAD-231176
Journal: Journal of Alzheimer's Disease, vol. 98, no. 2, pp. 403-409, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl